These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

457 related items for PubMed ID: 26941861

  • 1. Semi-Quantitative Analysis of Post-Transarterial Radioembolization (90)Y Microsphere Positron Emission Tomography Combined with Computed Tomography (PET/CT) Images in Advanced Liver Malignancy: Comparison With (99m)Tc Macroaggregated Albumin (MAA) Single Photon Emission Computed Tomography (SPECT).
    Rhee S, Kim S, Cho J, Park J, Eo JS, Park S, Lee E, Kim YH, Choe JG.
    Nucl Med Mol Imaging; 2016 Mar; 50(1):63-9. PubMed ID: 26941861
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy.
    Song YS, Paeng JC, Kim HC, Chung JW, Cheon GJ, Chung JK, Lee DS, Kang KW.
    Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 99mTc-macroaggregated albumin SPECT/CT predictive dosimetry and dose-response relationship in uveal melanoma liver metastases treated with first-line selective internal radiation therapy.
    Tabotta F, Gnesin S, Dunet V, Ponti A, Digklia A, Boughdad S, Schaefer N, Prior JO, Villard N, Tsoumakidou G, Denys A, Duran R.
    Sci Rep; 2023 Aug 12; 13(1):13118. PubMed ID: 37573346
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. High quality imaging and dosimetry for yttrium-90 (90Y) liver radioembolization using a SiPM-based PET/CT scanner.
    Duan H, Khalaf MH, Ferri V, Baratto L, Srinivas SM, Sze DY, Iagaru A.
    Eur J Nucl Med Mol Imaging; 2021 Jul 12; 48(8):2426-2436. PubMed ID: 33443618
    [Abstract] [Full Text] [Related]

  • 10. Accuracy and reproducibility of a cone beam CT-based virtual parenchymal perfusion algorithm in the prediction of SPECT/CT anatomical and volumetric results during the planification of radioembolization for HCC.
    Derbel H, Krichen M, Chalaye J, Saccenti L, Van der Sterren W, Muris AH, Lerman L, Galletto A, Zaarour Y, Luciani A, Kobeiter H, Tacher V.
    Eur Radiol; 2023 May 12; 33(5):3510-3520. PubMed ID: 36651956
    [Abstract] [Full Text] [Related]

  • 11. Feasibility of imaging 90 Y microspheres at diagnostic activity levels for hepatic radioembolization treatment planning.
    Kunnen B, Dietze MMA, Braat AJAT, Lam MGEH, Viergever MA, de Jong HWAM.
    Med Phys; 2020 Mar 12; 47(3):1105-1114. PubMed ID: 31855282
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Quantitative comparison of pre-therapy 99mTc-macroaggregated albumin SPECT/CT and post-therapy PET/MR studies of patients who have received intra-arterial radioembolization therapy with 90Y microspheres.
    Knešaurek K, Tuli A, Pasik SD, Heiba S, Kostakoglu L.
    Eur J Radiol; 2018 Dec 12; 109():57-61. PubMed ID: 30527312
    [Abstract] [Full Text] [Related]

  • 15. Assessing Spatial Concordance Between Theranostic Pairs Using Phantom and Patient-Specific Acceptance Criteria: Application to 99mTc-MAA SPECT/90Y-Microsphere PET.
    Mikell JK, Majdalany BS, Owen D, Paradis KC, Dewaraja YK.
    Int J Radiat Oncol Biol Phys; 2019 Aug 01; 104(5):1133-1140. PubMed ID: 31022511
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer.
    Knesaurek K, Machac J, Muzinic M, DaCosta M, Zhang Z, Heiba S.
    Technol Cancer Res Treat; 2010 Jun 01; 9(3):253-62. PubMed ID: 20441235
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 90 Y SPECT/CT quantitative study and comparison of uptake with pretreatment 99 m Tc-MAA SPECT/CT in radiomicrosphere therapy.
    Debebe SA, Adjouadi M, Gulec SA, Franquiz J, McGoron AJ.
    J Appl Clin Med Phys; 2019 Feb 01; 20(2):30-42. PubMed ID: 30628156
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.